CIRM grants ViaCyte $3.9 million for diabetes stem cell therapy – The San Diego Union-Tribune
The San Diego Union-Tribune |
CIRM grants ViaCyte $3.9 million for diabetes stem cell therapy
The San Diego Union-Tribune The grant from the California Institute for Regenerative Medicine brings ViaCyte's total CIRM funding to $60 million, as discussed by the California Stem Cell Report. Paul Laikind, ViaCyte's CEO, said in a statement that ViaCyte remains committed to … ViaCyte Awarded New CIRM Grant to Develop PEC-Direct for High-Risk Type 1 Diabetes |
